Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,871 total articles
Global Indemnity Group, a Nasdaq-listed insurance holding company, announced the appointment of Michele Colucci, founder of DigitalDx Ventures and expert in digital transformation and AI, to its Board of Directors. Colucci's extensive experience in technology, innovation, and risk management is expected to support GBLI's continued growth and evolut…
RenX Enterprises announced key milestones in deploying the Microtec UTM 1200 Turbo Mill at its Florida facility, including initiating a customer sample run in Germany, acquiring spare parts to minimize downtime, and funding contracts for on-site commissioning and electrical infrastructure. These steps advance the company's ability to produce and qu…
Creative Realities, Inc., a Nasdaq-listed provider of digital signage, media, and AdTech solutions, announced its participation in the upcoming Craig-Hallum Institutional Investor Conference. The company offers digital signage platforms and recurring SaaS services across multiple verticals including retail, automotive, and digital-out-of-home adver…
FTI Consulting's economic consulting arm, Compass Lexecon, has added two distinguished academic experts, Professor Anja Lambrecht and Professor Matthew Notowidigdo, as affiliates. Their specialties in digital economy marketing, labor, and health economics augment Compass Lexecon's capabilities to navigate complex regulatory and competition challeng…
Plus Therapeutics announced a strategic partnership with Ephemeral Technologies to deploy a novel AI execution platform that integrates and analyzes proprietary therapeutic, diagnostic, and bioinformatics datasets in central nervous system (CNS) oncology. This collaboration aims to enhance precision neuro-oncology by improving operational efficienc…
Alterity Therapeutics announced compelling data presentations supporting progression of their lead compound ATH434 into Phase 3 clinical trials for Multiple System Atrophy (MSA). The Phase 2 trial demonstrated statistically significant slowing of disease progression and favorable biomarker engagement, with novel MRI imaging techniques enabling earl…
SiTime Corporation announced a proposed offering of up to $1.1 billion aggregate principal amount of Convertible Senior Notes due 2031, with an option for underwriters to purchase an additional $150 million. The net proceeds are expected to partially fund the acquisition of certain assets from Renesas Electronics Corporation, costs related to cappe…
Gilat Satellite Networks and Boeing have achieved a milestone to offer Gilat's multi-orbit Sidewinder electronically steered antenna as a future line-fit option for in-flight connectivity (IFC) service providers. This compact ESA will simplify installation, reduce maintenance costs, and enable earlier service entry, supporting advanced broadband co…
Zenas BioPharma announced that safety and efficacy results from the Phase 3 INDIGO trial evaluating its lead candidate Obexelimab for Immunoglobulin G4-Related Disease (IgG4-RD) will be presented at the EULAR 2026 Congress. The INDIGO trial met its primary and all four key secondary endpoints with high statistical significance, demonstrating a 56% …
Antalpha Platform Holding Company announced robust Q1 2026 results with 52% year-over-year revenue growth and enhanced profitability driven by its scalable digital asset platform. The acquisition of Aurelion contributed significantly, boosting adjusted EBITDA margin to 64%. The company is advancing its tokenized gold strategy to generate yield and …
Cullinan Therapeutics announced that the FDA has granted Orphan Drug Designation to CLN-049, a novel FLT3xCD3 T cell engager under investigation for treating relapsed/refractory acute myeloid leukemia (AML). The designation supports the drug's potential to address significant unmet medical needs in AML, including in patients with poor prognosis due…
Garrett Motion Inc. announced its 2026 Technology and Investor Day scheduled for May 20, 2026, where it will present updates on its Turbo, Zero-Emission Vehicle, and Industrial technology portfolios, alongside its long-term growth strategies and financial priorities. The event will include real-time and replay webcast access.
Korro Bio announced the selection of KRRO-111, a proprietary GalNAc-conjugated oligonucleotide therapeutic, as a development candidate for treating Alpha-1 Antitrypsin Deficiency (AATD). KRRO-111 leverages the company's OPERA RNA editing platform to correct the pathogenic mutation in the SERPINA1 gene, achieving over 90% editing efficiency and sign…
Lexeo Therapeutics, a clinical-stage genetic medicine company focused on cardiovascular diseases, announced its participation in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference. The live webcast will provide insights into their pipeline targeting genetic causes of heart conditions, featuring candidates like LX2006 and L…
Ambow Education Holding Ltd. (NYSE American: AMBO) has launched the HybriU Collaboration Board, an AI-powered phygital tool providing real-time collaborative whiteboard access via a single QR code. This innovation enables participants to interact with various content types without software installation or accounts, aiming to enhance hybrid collabor…
OKYO Pharma Limited appoints international expert Dr. Marta Sacchetti, MD, PhD, to its Scientific Advisory Board. This strategic addition strengthens the company's expertise in neuro-inflammatory corneal diseases, aligning with its development of urcosimod, a promising investigational therapy for neuropathic corneal pain (NCP). Having completed a s…
Osisko Development Corp. has appointed Greg Perrins as Vice President of Sustainable Development to enhance its approach to Indigenous relations and public sector engagement in British Columbia. Perrins brings over 15 years of experience in natural resource sectors and government roles, aiming to support the company’s flagship Cariboo Gold Project …
Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced updated positive clinical data from its ongoing Expanded Access Program evaluating intranasal foralumab in 14 patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS). The data showed intranasal foralumab was well tolerated with no new safety signals, demonstrated trends toward …
Quantum Cyber N.V. announced the filing of a provisional patent application with the USPTO for an autonomous naval mine countermeasure system designed to detect and neutralize underwater mines using unmanned aerial vehicles. The technology is timely and directly addresses a current military crisis in the Strait of Hormuz where Iran has deployed nav…
EyePoint, Inc., a clinical-stage biopharmaceutical company focused on innovative therapeutics for serious retinal diseases, announced its participation in several upcoming investor conferences including Stifel, Jefferies, and Goldman Sachs. The company highlighted its lead product candidate, DURAVYU™, a sustained delivery treatment undergoing Phase…
Orion Energy Systems announced preliminary unaudited results for fiscal year 2026, posting $86 million in revenue and adjusted EBITDA of at least $2 million, marking six consecutive quarters of positive adjusted EBITDA. The company reiterated fiscal year 2027 guidance with projected revenues between $95 million and $97 million and positive adjusted…
Tecnoglass, a leading producer of high-end aluminum and vinyl windows and architectural glass, announced attendance at three major investor conferences in May and June 2026. The company highlights its strong presence in the U.S. market, accounting for 95% of its revenues, and its significant manufacturing footprint in Colombia.
XORTX Therapeutics Inc., a clinical-stage pharmaceutical company specializing in therapies for gout and kidney diseases, has completed a $5 million public offering through issuing common shares and pre-funded warrants. The proceeds will support working capital, corporate purposes, and investor relations activities. The offering was made under an SE…
Vertex Inc. published a new global study highlighting growing revenue risks caused by misalignment among IT, Tax, and Finance teams in compliance processes. Despite strong ambitions for collaboration, many organizations suffer from governance gaps, poor data quality, and fragmented ownership, risking blocked transactions and delayed revenue. The re…
Fury Gold Mines Limited has initiated an extensive metallurgical testwork program at its 100% owned Eau Claire gold project in Quebec to support ongoing feasibility studies. The program aims to optimize ore processing, support tailings management, and ensure environmental compliance, paving the way for a detailed process flowsheet and development p…
